AI uncovers a novel CBLB inhibitor for hard-to-treat tumors
Insilico Medicine - 01-Dec-2025ISM3830 boosts immune attack and delivers strong preclinical tumour control
Join the club for FREE to access the whole archive and other member benefits.
ISM3830 boosts immune attack and delivers strong preclinical tumour control
PEG-free stealth shield lets enzyme nanocarriers circulate 100+ hours and starve tumours in mice
The treatment is quick, easy, and gives hope to many patients
Targeted pill shows strong tumour reduction and better quality of life for HER2-mutant patients
LED treatment killed 92% of skin cancer and 50% of colorectal cancer cells safely
Click on resource name for more details.
Podcast from Beyond Biotech- Ken Herrmann and Molecular Partners on the Future of Targeted Cancer Therapy
Podcast from Beyond Biotech- German biotech launches to develop radiotherapy-based treatments
You: The Owner's Manual Podcast - EP 1,242B - Omid Veiseh on how cytokine implants could revolutionize cancer treatment
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology